Datalpha therapeutics
Datalpha therapeutics uses AI to improve safety and effectiveness in clinical trials. It builds foundational phenomic models to map patient-drug interactions, explaining how drugs affect different individuals. The company relies on AI, phenomics and data science to drive its platform for drug development. Its customers are pharma and biotech firms seeking to integrate advanced modeling into their clinical trial workflows. The goal is to scale safer, more predictive trials and accelerate drug development using AI-powered phenomics.
Datalpha therapeutics
Datalpha therapeutics uses AI to improve safety and effectiveness in clinical trials. It builds foundational phenomic models to map patient-drug interactions, explaining how drugs affect different individuals. The company relies on AI, phenomics and data science to drive its platform for drug development. Its customers are pharma and biotech firms seeking to integrate advanced modeling into their clinical trial workflows. The goal is to scale safer, more predictive trials and accelerate drug development using AI-powered phenomics.